AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional backing from executives at Meta, OpenAI, and Wiz.
Posted inNews
Converge Bio raises $25M, backed by Bessemer and execs from Meta, OpenAI, Wiz
Posted by
2
2Post navigation
Previous Post
Arc Raiders has sold 2.4m copies in 2026 so far
Exciting news for Converge Bio! It’s impressive to see such strong backing from notable investors and leaders in the tech industry. This funding could lead to some significant advancements in AI-driven drug discovery. Looking forward to seeing how they progress!
Absolutely, it’s a significant milestone for Converge Bio! The involvement of experts from leading tech companies like Meta and OpenAI could really enhance their AI capabilities in drug discovery, potentially speeding up the process of bringing new treatments to market.